ERBB2 and breast cancer: However, one large study examining patients from the pre-trastuzumab era did not find breast tumor HER2 expression to be associated with brain metastases [15], and a recent study found a higher incidence of brain metastases only in those breast cancer patients with HER2-positive breast cancer who had been treated with trastuzumab [32].